DENIS CHEM LAB
|
|
BOM : 537536     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : NA |
Dec 06,2024 |
Price(EOD): ₹ 166.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 230.81 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
DENIS CHEM LAB | -3.2% | 6.6% | 39.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.2% | 0.1% | 47% |
CIPLA | -2% | -7.7% | 23.2% |
DR REDDYS LABORATORIES | 2.6% | -1.5% | 7.9% |
ZYDUS LIFESCIENCES | 2.1% | 0.6% | 54.5% |
DIVIS LABORATORIES | -1.9% | 5.5% | 60.6% |
MANKIND PHARMA | -1.2% | -4.8% | 36.6% |
TORRENT PHARMACEUTICALS | -0.2% | 4.6% | 57.8% |
LUPIN | 3.1% | -2.2% | 68.7% |
FUNDAMENTAL ANALYSIS OF DENIS CHEM LAB
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF DENIS CHEM LAB
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
19.97
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 11.54 Cr
[Latest Qtr - Sep2024 - Standalone Results ] 2.87
P/B Calculated based on Book Value of Rs 80.37 Cr
[Latest Year - Mar2024 - Standalone Results ] 1.36
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
80% 47% 73% |
SHARE PRICE MOMENTUM OF DENIS CHEM LAB
DENIS CHEM LAB vs SENSEX
DEBT OF DENIS CHEM LAB
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.01 0.03 0.05 0.03 |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF DENIS CHEM LAB
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF DENIS CHEM LAB
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
15.9% 35.39% 61.11% 70.09% |
5.26% 14.45% 23.61% 38.8% |
QtrlyTrend |
8 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
DENIS CHEM LAB related INDICES
You may also like the below Video Courses
FAQ about DENIS CHEM LAB
Is DENIS CHEM LAB good for long term investment?
As on Dec 06,2024, the Fundamentals of DENIS CHEM LAB look Strong and hence it may be good for long term investment! See Financial Performance of DENIS CHEM LAB . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is DENIS CHEM LAB UnderValued or OverValued?
As on Dec 06,2024, DENIS CHEM LAB is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of DENIS CHEM LAB ?
As on Dec 06,2024, the Intrinsic Value of DENIS CHEM LAB is Rs. 95.78 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 92.10
Fair Value [Median EV / Sales Model] : Rs. 113.01
Fair Value [Median Price / Sales Model] : Rs. 95.78
Estimated Median Fair Value of DENIS CHEM LAB : Rs. 95.78
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.